Technology
Health
Biotechnology

MorphoSys

$27.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.11 (0.40%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MorphoSys and other stocks, options, ETFs, and crypto commission-free!

About MOR

CEO
Employees
329
Headquarters
Founded
1992
Market Cap
3.53B
Price-Earnings Ratio
Dividend Yield
Average Volume
57.29K
High Today
$28.27
Low Today
$27.93
Open Price
$28.23
Volume
129.87K
52 Week High
$35.90
52 Week Low
$21.75

Collections

Technology
Health
Biotechnology
Research And Development
Therapy
Pharmaceutical
2018 IPO
Europe (Non-UK)

MOR News

BenzingaJun 25

CORRECTION: Ad hoc: MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Executive Officer

2

MOR Earnings

-$1.57
-$0.68
$0.20
$1.09
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Aug 6, After Hours

More MOR News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.